Publicaciones (14) Publicaciones de BELEN MOLLA MOLINER

2022

  1. Frataxin Deficit Leads to Reduced Dynamics of Growth Cones in Dorsal Root Ganglia Neurons of Friedreich’s Ataxia YG8sR Model: A Multilinear Algebra Approach

    Frontiers in Molecular Neuroscience, Vol. 15

  2. Pharmacological Modulation of Glutamatergic and Neuroinflammatory Pathways in a Lafora Disease Mouse Model

    Molecular Neurobiology, Vol. 59, Núm. 10, pp. 6018-6032

2021

  1. Modulators of Neuroinflammation Have a Beneficial Effect in a Lafora Disease Mouse Model

    Molecular Neurobiology, Vol. 58, Núm. 6, pp. 2508-2522

2020

  1. Cofilin dysregulation alters actin turnover in frataxin-deficient neurons

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Phosphodiesterase Inhibitors Revert Axonal Dystrophy in Friedreich’s Ataxia Mouse Model

    Neurotherapeutics, Vol. 16, Núm. 2, pp. 432-449

2017

  1. Reversible axonal dystrophy by calcium modulation in frataxin-deficient sensory neurons of YG8R mice

    Frontiers in Molecular Neuroscience, Vol. 10

2016

  1. Two different pathogenic mechanisms, dying-back axonal neuropathy and pancreatic senescence, are present in the YG8R mouse model of Friedreich's ataxia

    DMM Disease Models and Mechanisms, Vol. 9, Núm. 6, pp. 647-657

2014

  1. Mitochondrial dysfunction induced by frataxin deficiency is associated with cellular senescence and abnormal calcium metabolism

    Frontiers in Cellular Neuroscience, Vol. 8, Núm. MAY

2011

  1. Differential expression of PGC-1α and metabolic sensors suggest age-dependent induction of mitochondrial biogenesis in friedreich ataxia fibroblasts

    PLoS ONE, Vol. 6, Núm. 6

2009

  1. Constitutive COX-2 activity in cardiomyocytes confers permanent cardioprotection. Constitutive COX-2 expression and cardioprotection

    Journal of Molecular and Cellular Cardiology, Vol. 46, Núm. 2, pp. 160-168

2008

  1. Constitutive expression of cyclo-oxygenase 2 transgene in hepatocytes protects against liver injury

    Biochemical Journal, Vol. 416, Núm. 3, pp. 337-346

2007

  1. Protection against Fas-induced liver apoptosis in transgenic mice expressing cyclooxygenase 2 in hepatocytes

    Hepatology, Vol. 45, Núm. 3, pp. 631-638

2006

  1. Cyclo-oxygenase 2 expression impairs serum-withdrawal-induced apoptosis in liver cells

    Biochemical Journal, Vol. 398, Núm. 3, pp. 371-380

2003

  1. Unique origin and low penetrance of the 946delGAG mutation in Valencia DYT1 families

    Clinical Genetics, Vol. 64, Núm. 2, pp. 153-159